Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTreatt Regulatory News (TET)

Share Price Information for Treatt (TET)

Share Price is delayed by 15 minutes
Get Live Data
301.50    -0.50 (-0.17%)
Bid:
302.00
Ask:
302.50
Spread: 0.50 (0.166%)
Market Cap: £177.99m
TET Live PriceLast checked at - London Stock Exchange

Intraday Treatt Share Chart

Share Buyback Programme

10 Apr 2025 07:01

RNS Number : 4134E
Treatt PLC
10 April 2025
 

10 April 2025

Treatt PLC

("Treatt" or the "Company")

Share Buyback Programme

Launch of Share Buyback Programme

Treatt PLC, the manufacturer and supplier of natural ingredients for the beverage, flavour and fragrance industries, is pleased to announce it will commence a share buyback programme (the "Share Buyback Programme"), as referenced in the Company's trading update released today.

Treatt has a strong balance sheet and the Board has considered the Share Buyback Programme as part of the Company's capital allocation framework, whilst also reflecting Treatt's strong cash performance together with the Board's confidence in Treatt's strategy and medium term outlook.

Details of the Share Buyback Programme

The Company has appointed its corporate brokers, Investec Bank plc ("Investec") and Peel Hunt LLP ("Peel Hunt") (together, the "Brokers"), to manage the share buyback programme to repurchase ordinary shares of 2 pence each in the capital of the Company (the "Ordinary Shares") on the Company's behalf from 10 April 2025, for a maximum aggregate consideration of £5 million (the "Buyback Amount"). The Share Buyback Programme will run until the earlier of the Buyback Amount being utilised in the repurchase of Ordinary Shares or the expiry of the 2025 Authority (defined below). Shares repurchased will be held in treasury at the Company's discretion for later reissue or cancellation.

Treatt has given irrevocable and non-discretionary instruction to Investec and Peel Hunt to conduct the Share Buyback Programme on its behalf. The Brokers will act as "riskless" or "matched" principals for the purposes of the Share Buyback Programme, within certain parameters, and will make trading decisions concerning the purchases of Ordinary Shares independently of the Company.

Shares purchased under the Share Buyback Programme will take place in open market transactions and in accordance with the general authority to purchase Ordinary Shares granted to the directors of the Company by its shareholders at the Company's annual general meeting in 2025 (the "2025 Authority"). The maximum number of Ordinary Shares which the Company is authorised to purchase under the 2025 Authority is 6,120,976. In accordance with the 2025 Authority, the maximum price (exclusive of expenses) which may be paid for an Ordinary Share is an amount equal to the higher of (i) 5% above the average of the middle market quotations for an Ordinary Share as derived from the London Stock Exchange Daily Official List on the five business days immediately preceding any Ordinary Shares being purchased and (ii) the higher of the price of the last independent trade and the highest current independent bid for Ordinary Shares on the trading venue where the purchase is carried out. Furthermore, in accordance with the 2025 Authority, the minimum price which may be paid for each Ordinary Share is 2 pence, being the nominal value of an Ordinary Share. The Share Buyback Programme will be conducted in accordance with Article 5(1) of Regulation (EU) 596/2014, as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 (as amended) ("UK MAR") and the provisions of Commission Delegated Regulation (EU) 2016/1052, as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 (as amended), which deal with buyback programmes. The Share Buyback Programme will also be conducted in accordance with Chapter 9 of the Financial Conduct Authority's UK Listing Rules.

Treatt will make further regulatory announcements in respect of repurchases of Ordinary Shares as required.

 

For further information, please contact:

 

Treatt PLC

David Shannon, Chief Executive Officer

Ryan Govender, Chief Financial Officer

 

+44 (0) 1284 702500

Investec Bank Plc - Joint Corporate Broker

+44 (0) 20 7597 5970

Patrick Robb

David Anderson

Shalin Bhamra

 

Peel Hunt LLP - Joint Corporate Broker

+44 (0) 20 7418 8900

George Sellar

Andrew Clark

Finn Nugent

 

MHP - Financial PR

+44 (0) 20 3128 8100

Tim Rowntree

Eleni Menikou

Veronica Farah

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCSSSEFUEISEIL
Date   Source Headline
16th Jan 20205:07 pmRNSHolding(s) in Company
9th Jan 20202:28 pmRNSDirector/PDMR Shareholding - Replacement
8th Jan 20205:04 pmRNSDirector/PDMR Shareholding
7th Jan 20205:16 pmRNSHolding(s) in Company
6th Jan 202011:18 amRNSDirector/PDMR Shareholding
24th Dec 201910:54 amRNSVoting Rights and Capital
18th Dec 20194:03 pmRNSNotification of Transactions of Directors
17th Dec 20194:04 pmRNSDirector/PDMR Shareholding
10th Dec 201912:15 pmRNSAnnual Report
6th Dec 20194:12 pmRNSHolding(s) in Company
2nd Dec 20194:44 pmRNSBLOCK LISTING SIX MONTHLY RETURN
2nd Dec 20194:43 pmRNSBLOCK LISTING SIX MONTHLY RETURN
26th Nov 20197:00 amRNSFinal Results
25th Nov 201912:07 pmRNSSecond Price Monitoring Extn
25th Nov 201912:02 pmRNSPrice Monitoring Extension
22nd Nov 20194:35 pmRNSPrice Monitoring Extension
21st Nov 20193:11 pmRNSBoard Committee Change
6th Nov 20199:44 amRNSHolding(s) in Company
25th Oct 20194:40 pmRNSSecond Price Monitoring Extn
25th Oct 20194:35 pmRNSPrice Monitoring Extension
4th Oct 20197:00 amRNSTrading Update
30th Sep 20194:57 pmRNSNotification of Transaction of a Director
17th Sep 20197:00 amRNSUpdate on Site Relocation
3rd Sep 201912:04 pmRNSDirector/PDMR Shareholding
3rd Sep 201912:01 pmRNSNotification of Transaction of a Director
2nd Sep 20194:55 pmRNSVoting Rights and Capital
21st Aug 201912:07 pmRNSSecond Price Monitoring Extn
21st Aug 201912:02 pmRNSPrice Monitoring Extension
19th Aug 20192:49 pmRNSDirector/PDMR Shareholding
9th Aug 20197:00 amRNSBlock Listing Application
1st Aug 20193:35 pmRNSTotal Voting Rights
25th Jul 201912:07 pmRNSSecond Price Monitoring Extn
25th Jul 201912:02 pmRNSPrice Monitoring Extension
24th Jul 20193:26 pmRNSDirector/PDMR Shareholding
22nd Jul 20194:40 pmRNSSecond Price Monitoring Extn
22nd Jul 20194:35 pmRNSPrice Monitoring Extension
18th Jul 201912:07 pmRNSSecond Price Monitoring Extn
18th Jul 201912:02 pmRNSPrice Monitoring Extension
10th Jul 201912:07 pmRNSSecond Price Monitoring Extn
10th Jul 201912:02 pmRNSPrice Monitoring Extension
8th Jul 201912:02 pmRNSPrice Monitoring Extension
3rd Jul 20194:07 pmRNSHolding(s) in Company
2nd Jul 20193:37 pmRNSTotal Voting Rights
2nd Jul 201912:07 pmRNSSecond Price Monitoring Extn
2nd Jul 201912:02 pmRNSPrice Monitoring Extension
10th Jun 20194:40 pmRNSSecond Price Monitoring Extn
10th Jun 20194:35 pmRNSPrice Monitoring Extension
4th Jun 20194:26 pmRNSBlock Listing Six Monthly Return
15th May 20191:02 pmRNSDirector Declaration
14th May 20197:00 amRNSBoard Committee Changes

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.